TrialThe Lancet. Neurology2019

Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial.

Johannes Levin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.